 |
 |
 |
|
Health Care Data . Research . Consulting
Business intelligence is a critical requisite for today's knowledge-based marketplace.
Brogan Inc. is your partner for providing timely market intelligence, insightful and in-depth research, and strategic solutions to current issues in the Canadian health care market.
Serving all major pharmaceutical companies, insurers, and government organizations in Canada, Brogan Inc. offers solutions to help our clients leverage the power of business intelligence to:
· Detect and exploit emerging trends
· Make proactive decisions
· Fine tune strategies for success, and
· Gain competitive advantage
For more information contact us.
|
|
|
|
|
|
|
|
|
|
 |
|
Latest Provincial Formulary Updates.
Read more »
New Brogan Inc. report on impact of the recession on prescription drug sales
Read more »
CDR Recent Recommendations: Vesicare, Stelara and Fosavance 70/5600
Read more »
Changes in the PMPRB 2010 Guidelines compared to March 2009 Proposals
Read more »
CDR Recent Recommendations: Olmetec and Olmetec Plus
Read more »
CDR Recent Recommendations: Enablex, Orencia and Remicade
Read more »
Update on the Consultation Process and other information from the PMPRB Newsletter
Read more »
PMPRB Releases Draft New Compendium
Read more »
CDR Recent New Recommendations: Tysabri and Viread
Read more »
Strattera Voluntary Compliance Undertaking
Read more »
CDR Published a New Recommendation on February 20, 2009: Apidra
Read more »
CDR published four final recommendations on Jan 30, 2009: Pradax, Relistor, Thelin and Xyrem
Read more »
PMPRB Newsletter - summary
Read more »
December 2008 CPI release
Read more »
CEDAC made three new recommendations on Dec 17, 2008: Xarelto, Volibris and Truvada
Read more »
Prevalence of opioid dispensing and concurrent gastrointestinal medications in Quebec
Read more »
PMPRB temporarily suspending mandatory reporting of benefits until June 2009
Read more »
October CPI is published
Read more »
CEDAC made two new recommendations on Nov 12, 2008: Celsentri and Omnaris
Read more »
Access to New Medicines in Canada: A Look at CDR Reviewed Products
Read more »
PMPRB Newsletter - Summary
Read more »
PMPRB Publishes New Proposed Guidelines
Read more »
PMPRB announces that ALL benefits must be filed and included in ATP
Read more »
Quebec - Updated List of Medications
Read more »
Working Group on Price Tests and CGPA Working Group Reports Published; Reminder: Publication of New Proposed Guidelines; Brogan Seminars
Read more »
PMPRB July Newsletter - Summary
Read more »
New Notices of Hearing, Adderall XR on Admissibility of Evidence, and Brogan Fall Seminars
Read more »
Competitive Agreement Ontario
Read more »
PMPRB Fundamentals Seminar
Read more »
PMPRB Advanced Seminar
Read more »
PMPRB Annual Report 2007
Read more »
PMPRB Newsletter Summary
Read more »
PMPRB Releases Adderall XR Decision
Read more »
Amendments to Patented Medicines Regulations, Responses to Discussion Paper, Apotex Hearing, and VCUs
Read more »
Brogan Inc. entered into an agreement with Rotman School of Management
Read more »
PMPRB issues a Notice of Hearing and Notice of Application in regards to Apotex Inc.
Read more »
Brogan comments on the PMPRB’s January 2008 Discussion Paper
Read more »
Board Issues Copaxone Decision
Read more »
Recent Publications: Effect of Cost-Sharing on Use of Asthma Medication in Children
Read more »
January 2008 NEWSletter Released.
Read more »
The Board releases its Discussion Paper. You are invited to submit your comments no later than March 3, 2008.
Read more »
PMPRB Club: Federal Court Decision on Pre-Patent Jurisdiction, Actual vs. Forecast CPI, and Exchange Rates December 2007
Read more »
|
|
|
|
|
|
